• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Ubiquitin-associated protein 2-like (UBAP2L), Truncated

ACP17856

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP17856 Target NameUBAP2L
Target SynonymsFLJ42300; KIAA0144; NICE 4; NICE4; Protein NICE-4; Protein NICE4; Ubap2l; Ubiquitin associated protein 2 like; Ubiquitin-associated protein 2-like; UBP2L_HUMANFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ14157
Background Information
  • Uniprot Id

    Q14157

  • Target Species

    Human

  • Target Name

    UBAP2L

  • Target Full Name

    Ubiquitin-associated protein 2-like

  • Target Function

    Plays an important role in the activity of long-term repopulating hematopoietic stem cells (LT-HSCs). Required for efficient formation of stress granules.

  • Target Subcellular Location

    Cytoplasm, Stress granule.

  • Target Tissue Specificity

    Ubiquitous.

  • Target Synonyms

    FLJ42300; KIAA0144; NICE 4; NICE4; Protein NICE-4; Protein NICE4; Ubap2l; Ubiquitin associated protein 2 like; Ubiquitin-associated protein 2-like; UBP2L_HUMAN

  • Target Background

    Enables RNA binding activity. Involved in binding activity of sperm to zona pellucida and stress granule assembly. Acts upstream of or within hematopoietic stem cell homeostasis. Part of PcG protein complex.

Inquire Recombinant Human Ubiquitin-associated protein 2-like (UBAP2L), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification